|
66
|
Coordination in gene expression during atherogenesis.
Shchelkunova TA, Morozov IA, Rubtsov PM, Samokhodskaya LM, Sobenin IA, Orekhov AN, Smirnov AN.
Biochemistry (Mosc). 2013 Aug;78(8):933-45. doi: 10.1134/S0006297913080117.
|
|
67
|
Association of mitochondrial genetic variation with carotid atherosclerosis.
Sobenin IA, Sazonova MA, Postnov AY, Salonen JT, Bobryshev YV, Orekhov AN.
PLoS One. 2013 Jul 9;8(7):e68070. doi: 10.1371/journal.pone.0068070. Print 2013.
|
|
68
|
Changes in levels of gene expression in human aortal intima during atherogenesis.
Shchelkunova TA, Morozov IA, Rubtsov PM, Samokhodskaya LM, Andrianova IV, Sobenin IA, Orekhov AN, Smirnov AN.
Biochemistry (Mosc). 2013 May;78(5):463-70. doi: 10.1134/S0006297913050040.
|
|
69
|
Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion
Nikoforov NG, Gratchev AN, Sobenin IA, Orekhov AN, Kzhyhskowska YG.
Patol Fiziol Eksp Ter. 2013 Jan-Mar;(1):109-17.
|
|
70
|
Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta.
Shchelkunova TA, Morozov IA, Rubtsov PM, Bobryshev YV, Sobenin IA, Orekhov AN, Andrianova IV, Smirnov AN.
PLoS One. 2013 May 23;8(5):e63374. doi: 10.1371/journal.pone.0063374. Print 2013.
|
|
71
|
Association of the level of heteroplasmy of the 15059G>A mutation in the MT-CYB mitochondrial gene with essential hypertension.
Sobenin IA, Chistiakov DA, Sazonova MA, Ivanova MM, Bobryshev YV, Orekhov AN, Postnov AY.
World J Cardiol. 2013 May 26;5(5):132-40. doi: 10.4330/wjc.v5.i5.132.
|
|
72
|
Changes of lysosomes in the earliest stages of the development of atherosclerosis.
Bobryshev YV, Shchelkunova TA, Morozov IA, Rubtsov PM, Sobenin IA, Orekhov AN, Smirnov AN.
J Cell Mol Med. 2013 May;17(5):626-35. doi: 10.1111/jcmm.12042. Epub 2013 Mar 14.
|
|
73
|
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy.
Sobenin IA, Chistiakov DA, Bobryshev YV, Orekhov AN.
Curr Pharm Des. 2013;19(33):5954-62.
|
|
74
|
Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
Sobenin IA, Chistiakov DA, Bobryshev YV, Postnov AY, Orekhov AN.
Curr Pharm Des. 2013;19(33):5942-53.
|
